Part II. What Do We Get for All That Money? A preventable epidemic of injury and death from prescription drugs; FDA’s contribution to the epidemic; Big Pharma’s business model: manufactured myths, propaganda and a hidden agenda;
FDA
FDA to Approve PET Scan for Alzheimer’s?
America’s health care expenditure is about to go through the roof–without improving anyone’s health! Continue reading →
FDA Acknowledges Caving to Influence Peddling–ReGen / ECT
Dr. Joshua Sharfstein, the FDA’s principal deputy commissioner, acknowledged: “The message here is that there were problems with the integrity of F.D.A.’s decision-making process that have solutions.” Continue reading →
Top FDA Officials, Compromised by Conflicts of Interest
Two high ranking FDA officials’ conflicts of interest have led one to resign, the other is under investigation by the Inspector General of the Department of Health and Human Services:
Continue reading →
Does the FDA have the authority to trump the Declaration of Helsinki?
The FDA is sliding rapidly down the slippery slope, abandoning widely accepted, international ethical research standards articulated in the internationally accepted, Declaration of Helsinki–to facilitate commercial medical experiments.
Continue reading →
Conflicts for FDA committee set to weigh risks of Seroquel_Philadelphia Inquirer
FDA officials who continue to run its powerful center for drug evaluation (CDER) have once again shown bad faith by appointing financially compromised doctors to the Psychopharmacologic Drugs Advisory Committee (PDAC) advisory panel. Continue reading →
Obama picks Duo to Run FDA: Dr Hamburg, Commissioner; Dr. Sharfstein Deputy
Dr. Margaret "Peggy" Hamburg, a former health commissioner in New York City, is the leading candidate to become FDA commissioner, the agency's top job, while Baltimore health chief Joshua Sharfstein is in line to become a deputy commissioner Continue reading →
Obama’s Health Plan Could be Hijacked by Industry Which Sees Good Business
The Washington Post suggests, the chance for success in overhauling US healthcare depends on President Obama's ability to keep the major–discordant–players on board. Continue reading →
Letter of Complaint Re: FDA Double Agent
A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels. Continue reading →
Letter of Complaint to FDA Commissioner, 2007
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion. Continue reading →
HPV Vaccine Researcher Blasts Mandatory Marketing
Dr. Diane M. Harper, a lead researcher in the development of the humanpapilloma virus vaccine, who says giving the drug to 11-year-old girls "is a great big public health experiment."
Continue reading →
The Health Care Racket_Paul Krugman NYT
"it's an arms race between insurers, who deploy software and manpower trying to find claims they can reject, and doctors and hospitals, who deploy their own forces in an effort to outsmart or challenge the insurers. Continue reading →